GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: GLAXO and BSE: 500660 (ISIN INE159A01016).
It has a market capitalisation of ₹42,275 crore, a last close of ₹2,495 on 2026-10-19, a one-year return of -9.0%.
Valuation: a price-to-earnings ratio of 39.58x, a price-to-book ratio of 18.64x, a dividend yield of 2.3%.
Profitability: return on equity of 49.1%, return on capital employed of 59.3%, an operating margin of 34.2%.
Growth: sales growth of 5.5% a year over three years, net profit growth of 19.3% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 75.0%.
| Metric | Value |
|---|---|
| Market capitalisation | 42,275 |
| Last close | ₹2,495 |
| P/E (TTM) | 39.58x |
| P/B | 18.64x |
| Dividend yield | 2.3% |
| ROE (FY) | 49.1% |
| ROCE (FY) | 59.3% |
| Operating margin (TTM) | 34.2% |
| Sales growth, 3-year CAGR | 5.5% |
| Profit growth, 3-year CAGR | 19.3% |
| Debt / equity | 0.00x |
| Promoter holding | 75.0% |
| 1-year return | -9.0% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means